Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

MYGNMYGN
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in MYRIAD GENETICS INC

GOLDMAN SACHS GROUP INC holds 2.1M shares of MYGN (MYRIAD GENETICS INC), worth $11.7M as of 2026-Q2. The position was decreased (-13.1% shares). MYGN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$11.7M

Current Shares

2.1M

Total Value Change

+$1.2M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.1M
-13.1%
$11.7M0.0%$5.71
0
2026-Q1
Increased
2.4M
+9.5%
$10.6M0.0%$5.29
30
2025-Q4
Increased
2.2M
+0.4%
$13.3M0.0%$6.17
28
2025-Q3
Increased
2.2M
+67.7%
$15.6M0.0%$7.24
42
2025-Q2
Increased
1.3M
+79.7%
$6.8M0.0%$5.25
42
2025-Q1
Decreased
714,095
-7.3%
$6.3M0.0%$8.88
0
2024-Q4
New
770,411
-
$10.6M0.0%$13.63
38

Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used